By Matthew Lee

The Trump administration has formally notified the United Nations of its withdrawal from the World Health Organization, although the pullout won’t take effect until next year, meaning it could be rescinded under a new administration of if circumstances change.

The withdrawal notification, delivered on Monday, makes good on President Donald Trump’s vow in late May to terminate U.S. participation in the WHO, which he has harshly criticized for its response to the coronavirus pandemic and accused of bowing to Chinese influence. The move was immediately assailed by health officials and critics of the administration.

The withdrawal notice was sent to U.N. Secretary-General Antonio Guterres on Monday and will take effect in a year, on July 6, 2021, the State Department and the United Nations said on Tuesday.

Guterres, in his capacity as depositary of the 1946 WHO constitution, "is in the process of verifying with the World Health Organization whether all the conditions for such withdrawal are met,” his spokesman, Stephane Dujarric, said.

Under the terms of the withdrawal, the U.S. must meet its financial obligations to the WHO before it can be finalized. The U.S., which is the agency's largest donor and provides it with more than $400 million per year, currently owes the WHO some $200 million in current and past dues.

In late May, less than two weeks after warning the WHO that it had 30 days to reform or lose U.S. support, Trump announced his administration was leaving the organization due to what he said was its inadequate response to the initial outbreak of the coronavirus in China’s Wuhan province late last year.

The president said in a White House announcement that Chinese officials “ignored” their reporting obligations to the WHO and pressured the organization to mislead the public about an outbreak that has now killed more than 130,000 Americans.

“We have detailed the reforms that it must make and engaged with them directly, but they have refused to act,” Trump said at the time. "Because they have failed to make the requested and greatly needed reforms, we will be today terminating the relationship.”

The withdrawal notification was widely denounced as misguided, certain to undermine an important institution that is leading vaccine development efforts and drug trials to address the COVID-19 outbreak.

“The administration’s move to formally withdraw from WHO amid the greatest public health crisis that Americans and the world have faced in a century is short-sighted, unnecessary, and unequivocally dangerous," said UN Foundation President Elizabeth Cousens. “WHO is the only body capable of leading and coordinating the global response to COVID-19. Terminating the U.S. relationship would undermine the global effort to beat this virus — putting all of us at risk.”

The ONE Campaign, which supports international health projects, called it an “astounding action” that jeopardizes global health.

“Withdrawing from the World Health Organization amidst an unprecedented global pandemic is an astounding action that puts the safety of all Americans and the world at risk. The U.S. should use its influence to strengthen and reform the WHO, not abandon it at a time when the world needs it most," ONE president Gayle Smith said.

Share:
More In Politics
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More